Tutor Perini (NYSE:TPC) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “Tutor Perini Corporation provides diversified general contracting, construction management and design-build services to private clients and public agencies worldwide. The company operates in four segments: Civil, Building, Specialty Contractors, and Management Services. The Civil segment engages in public works construction activities and the repair, replacement, and reconstruction of infrastructure. The Building segment offers services in specialized building markets, including hospitality and gaming, transportation, healthcare, municipal offices, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial, and high technology. The Specialty Contractors segment provides plumbing, HVAC, electrical, mechanical, and concrete services for the industrial, commercial, hospitality and gaming, and transportation markets. The Management Services segment offers construction and design-build services to the U.S. military and government agencies, and multi-national corporations. “
Hot High Tech Stocks To Invest In Right Now: Gevo, Inc.(GEVO)
Gevo, Inc. (Gevo), incorporated on June 9, 2005, is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock. It has two operating segments: the Gevo, Inc. segment and the Gevo Development/Agri-Energy segment. Its Gevo, Inc. segment is responsible for research and development activities related to the future production of isobutanol, including the development of its biocatalysts, the production and sale of biojet fuel, its Retrofit process and the next generation of chemicals and biofuels that will be based on its isobutanol technology. Its Gevo, Inc. segment also develops, maintains and protects its intellectual property portfolio, develops future markets for its isobutanol and provides corporate oversight services. Its Gevo Development/Agri-Energy segment is responsible for the operation of its Agri-Energy Facility and the production of ethanol, isobutanol and related products.
The Company has developed the Gevo Integrated Fermentation Technology (GIFT), an integrated technology platform for the production and separation of renewable isobutanol in order to produce and sell isobutanol made from renewable sources. GIFT consists of two components: biocatalysts that convert sugars derived from multiple renewable feed stocks into isobutanol through fermentation and a separation unit that is designed to continuously separate isobutanol during the fermentation process. GIFT is designed to permit the retrofit of existing ethanol capacity to produce isobutanol, ethanol or both products simultaneously or the addition of renewable isobutanol or ethanol production capabilities to a facility’s existing ethanol production by adding additional fermentation capacity side-by-side with the facility’s existing ethanol fermentation capacity (collectively refer! red to as Retrofit). Just like ethanol production, after fermentation, a primary product (isobutanol) and a co-product (iDGs) are recovered for sale. The main modifications of the GIFT system are replacing the ethanol producing yeast with Gevo’s isobutanol producing biocatalyst, and adding low temperature distillation equipment for continuous removal and separation of isobutanol. The Company has also developed new technologies using ethanol as a feedstock for the production of hydrocarbons, renewable hydrogen, and other chemical intermediates, which it describes as its ethanol-to-olefins (ETO) technologies. The process produces tailored mixes of isobutylene, propylene, hydrogen and acetone, which are used as standalone molecules, or as feedstocks to produce other chemical products and longer chain alcohols. At this time, this technology has only been operated at a laboratory scale.
The Company competes with Butamax Advanced Biofuels LLC, Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., Eastman Chemicals Company, Green Biologics Ltd., Shell Oil Company, DuPont-Danisco Cellulosic Ethanol LLC, Abengoa Bioenergy, S.A., POET, LLC, ICM, Mascoma Corporation, Inbicon A/S, INEOS New Planet BioEnergy LLC, Coskata, Inc., Archer Daniels Midland Company, BlueFire Ethanol, Inc., IncZeaChem Inc., ZeaChem Inc., Iogen Corporation, Qteros, Inc., Global Bioenergies, S.A., Virent Energy Systems, Inc., Renewable Energy Group, Inc., Amyris Biotechnologies, Inc. and Valero Energy Corporation.
- [By Ethan Ryder]
Shares of Gevo Inc (NASDAQ:GEVO) traded down 5.9% on Thursday . The company traded as low as $4.12 and last traded at $4.29. 529,018 shares changed hands during mid-day trading, a decline of 36% from the average session volume of 832,918 shares. The stock had previously closed at $4.56.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Gevo (GEVO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot High Tech Stocks To Invest In Right Now: Vascular Biogenics Ltd.(VBLT)
Vascular Biogenics Ltd., incorporated on January 31, 2000, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company’s program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. Its lead product candidate, VB-111(ofranergene obadenovec), is a gene-based biologic that it is developing for solid tumor indications, with a program for recurrent glioblastoma (rGBM), a form of brain cancer. It also is engaged in conducting a program focusing anti-inflammatory diseases, based on the use of its Lecinoxoid platform technology. Lecinoxoids are a class of small molecules it developed that are structurally and functionally similar to naturally occurring molecules known to modulate inflammation. The lead product candidate from this program, VB-201, is a Phase II-ready molecule that demonstrated efficacy in reducing vascular inflammation in a Phase II sub-study in psoriatic patients with cardiovascular risk.
The Company’s VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. VTS is both tissue- and condition-specific, allowing for targeted and limited gene expression in endothelial cells, the thin layer of cells that lines the interior surface of blood vessels undergoing angiogenesis. Its VTS platform technology comprises three components: a viral vector, a promoter and a transgene. The viral vector is a modified virus that is used as a delivery vehicle to distribute the promoter and the transgene throughout the body. The promoter is its genetically modified promoter, PPE-1-3X, which specifically targets the endothelial cells of angiogenic blood vessels. The transgene is a genetic sequence designed to yield a specific biologic effect, the expression of which is directed by PPE-1-3X.
The Company has studied VB-111 in a Phase I all comers trial involving patients with multiple types of metastatic cancer types, including thyroid cancer, neuroendocrine cancer, renal cell carcinoma and lung cancer. In that trial, VB-111 was tolerated and showed a dose- dependent extension in median overall survival across a range of tumor types. Its VTS platform technology enables systemic administration of gene therapy to either destroy or promote angiogenic blood vessels. It has also generated additional product candidates, which utilize the same vector and promoter as in VB-111, and comprise alternative functional transgenes, which include VB-511, an anti-angiogenic candidate; VB-211 and VB-411, which are pro-angiogenic candidates that may be employed for ischemic conditions, such as peripheral vascular disease.
The Company’s Lecinoxoid platform technology comprises a family of orally administered small molecules designed to modulate the body’s inflammatory response. Lecinoxoids are compounds that are structurally and functionally similar to naturally occurring molecules, known as oxidized phospholipids, which possess immune modulating anti-inflammatory properties, modified to manage stability and activity. Its lead Lecinoxoid-based compound, VB-201, is designed as an oral agent for the control of chronic inflammatory disorders. VB-201 inhibits the CD-14/TLR4 and TLR2 pathways, as well as monocyte migration. The Company has also developed second and third generations of Lecinoxoid product candidates.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering
- [By Lisa Levin] Companies Reporting Before The Bell
Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.
Hot High Tech Stocks To Invest In Right Now: PacWest Bancorp(PACW)
PacWest Bancorp, incorporated on March 24, 2008, is a bank holding company for Pacific Western Bank (the Bank). The Company is focused on relationship-based business banking to small, middle-market and venture-backed businesses. The Bank offers a range of loan and deposit products and services through approximately 80 branches located throughout the state of California. The Company provides commercial banking services, and deposit and treasury management services to small and middle-market businesses. It offers products and services under the brand names of Pacific Western, as well as its business groups, CapitalSource Inc. and Square 1 Bank. CapitalSource focuses on providing cash flow, asset-based, equipment and real estate loans and treasury management services to middle market businesses. Square 1 Bank focuses on providing a range of financial products to service entrepreneurial businesses and their venture capital and private equity investors. Square 1 Asset Management, Inc., a subsidiary of the Bank, provides investment advisory and asset management services.
The Company conducts a range of commercial lending activities that includes real estate mortgage, real estate construction and land loans, and commercial and industrial (C&I) loans and leases. Its commercial real estate loans are secured by a range of property types. Its C&I loan offerings are diverse and include various asset-secured loans, equipment-secured loans and leases, cash flow loans (leveraged loans) to finance business acquisitions and recapitalizations, and venture loans to support the operations of entrepreneurial companies during the various phases of their start-up operations. Its C&I loans include cash flow loans, asset-based loans, equipment-secured loans and leases, and venture capital loans. Its real estate lending activities focuses on loans to professional developers and real estate investors for the acquisition, refinancing and construction of commercial real estate. Its con! sumer loans include personal loans, auto loans, home equity lines of credit, revolving lines of credit, other loans made by banks to individual borrowers, and purchased participation interests in student loans originated and serviced by a third-party lender. The Company’s total loans are approximately $14.48 billion.
The Company’s investment securities are classified as securities available-for-sale. The Company’s investment portfolio consists of obligations of states and political subdivisions (municipal securities), the United States Government agency obligations, and government-sponsored enterprise (GSE) obligations. The Company owns approximately $3.6 billion of investment securities available-for-sale.
Sources of Funds
The Company’s main source of funds to support its revenue-generating assets and to provide a source of low-cost funds and deposit-related fee income are deposits. The Company offers deposit products to businesses and other customers with a range of rates and terms, including demand, money market and time deposits. It also provides international banking services, multi-state deposit services, asset management services, as well as product offerings through other correspondent banks. The Company’s total deposits consist of approximately $10.6 billion in core deposits, approximately $4.2 billion in time deposits and over $0.9 billion in brokered non-maturity deposits. The Company borrows funds on a long-term, short-term or overnight basis from the Federal Home Loan Banks (FHLB), the Federal Reserve Bank of San Francisco (FRBSF) or other financial institutions.
- [By Max Byerly]
ValuEngine upgraded shares of PacWest Bancorp (NASDAQ:PACW) from a sell rating to a hold rating in a research report report published on Wednesday morning.
- [By Ethan Ryder]
PacWest Bancorp (NASDAQ:PACW) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.
PagSeguro Digital (NYSE:PAGS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.
- [By Shane Hupp]
PacWest Bancorp (NASDAQ:PACW) – Stock analysts at Wedbush reduced their Q1 2019 earnings per share estimates for shares of PacWest Bancorp in a research report issued on Wednesday, September 12th. Wedbush analyst D. Chiaverini now forecasts that the financial services provider will earn $0.89 per share for the quarter, down from their prior estimate of $0.90. Wedbush currently has a “Neutral” rating on the stock. Wedbush also issued estimates for PacWest Bancorp’s Q1 2020 earnings at $0.98 EPS and Q2 2020 earnings at $1.02 EPS.
Hot High Tech Stocks To Invest In Right Now: CPS Technologies Corp.(CPSH)
CPS Technologies Corporation produces and sells advanced material solutions to the transportation, automotive, energy, computing/Internet, telecommunication, aerospace, defense, and oil and gas markets. Its products are used in applications that involve energy use or energy generation. The company primarily offers metal matrix composites that are a combination of metal and ceramic, such as baseplates for various applications, including motor controllers used in electric trains, subway cars, wind turbines, and hybrid and electric vehicles; baseplates and housings for use in radar, satellite, and avionics applications, as well as in modules built with wide band gap semiconductors; and lids and heatspreaders used with integrated circuits for use in Internet switches and routers. It also assembles housings and packages for hybrid circuits. CPS Technologies Corporation primarily sells its products to microelectronics systems houses in the United States, Europe, and Asia. The company was formerly known as Ceramics Process Systems Corporation and changed its name to CPS Technologies Corporation in March 2007. CPS Technologies Corporation was incorporated in 1984 and is headquartered in Norton, Massachusetts.
- [By Max Byerly]
Media coverage about CPS Technologies (NASDAQ:CPSH) has been trending somewhat negative recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CPS Technologies earned a media sentiment score of -0.04 on Accern’s scale. Accern also gave news headlines about the electronics maker an impact score of 47.6937573591172 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Hot High Tech Stocks To Invest In Right Now: ING Group, N.V.(ISP)
ING Groep N.V. (ING) is a financial institution. The Company offers banking services. The Company’s segments include Retail Netherlands, which offers current and savings accounts, business lending, mortgages and other consumer lending in the Netherlands; Retail Belgium, which offers products are similar to those in the Netherlands; Retail Germany, which offers current and savings accounts, mortgages and other customer lending; Retail Other, which offers products are similar to those in the Netherlands, and Wholesale Banking, which offers wholesale banking activities (a full range of products from cash management to corporate finance), real estate and lease. The Company’s Retail Banking business lines provide products and services to individuals, small and medium-sized enterprises (SMEs) and mid-corporates. ING Bank’s subsidiary in the United States is ING Financial Holdings Corporation. Advisors’ Opinion:
- [By Logan Wallace]
Berenberg Bank set a €2.20 ($2.56) price target on Intesa Sanpaolo (BIT:ISP) in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the stock.
- [By Ethan Ryder]
Intesa Sanpaolo (BIT:ISP) has been given a €2.15 ($2.50) target price by stock analysts at UBS Group in a research note issued on Tuesday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock.
- [By Stephan Byrd]
Intesa Sanpaolo (BIT:ISP) received a €2.90 ($3.37) price target from research analysts at Deutsche Bank in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the stock.
- [By Logan Wallace]
Jefferies Financial Group set a €2.05 ($2.38) target price on Intesa Sanpaolo (BIT:ISP) in a report published on Tuesday. The brokerage currently has a neutral rating on the stock.
Hot High Tech Stocks To Invest In Right Now: DraftKings Inc.(DKNG)
DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States. It operates through two segments, Business-to-Consumer and Business-to-Business. The company provides users with daily sports, sports betting, and iGaming opportunities. It is also involved in the design, development, and licensing of sports betting and casino gaming platform software for online and retail sportsbook, and casino gaming products. The company distributes its product offerings through various channels, including traditional websites and direct app downloads, as well as direct-to-consumer digital platforms, such as the Apple App store and the Google Play store. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
- [By Thomas Niel]
Like other “meme stocks,” a lot of the appeal with FUBO stock is its chance of getting short-squeezed. Short interest runs high (currently 17.5% of float), as bears are betting big that the company’s sports streaming/wagering platform will fail to find success due to high competition from big media, as well as from early-movers in the online sportsbook space such as DraftKings (NASDAQ:DKNG).
- [By Dana Blankenhorn]
If there’s a stock perfect for the “Bro Investor” who likes risk, action, and (potentially) a big pay-off, it’s DraftKings (NASDAQ:DKNG).